GlassScriptPhysician profile
Benjamin Gocial
NPI 1104983766
$16,285.04
in general payments reported to CMS, 2019-2025
18 companies · $408 in 2025
The $408 reported for 2025 was more than what 84% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $44.48 · 2021: $147 · 2022: $325 · 2023: $105 · 2024: $502 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $12,604.05 | 2019 | |
| Olympus Corporation of The Americas | $1,410.79 | 2019 | |
| Ferring Pharmaceuticals INC. | $523.53 | 2019-2025 | Menopur |
| Olympus Corporation | $300.00 | 2019 | |
| Organon LLC | $263.64 | 2022-2025 | Ganirelix Acetate, Pregnyl, Follistim Aq |
| Caldera Medical, INC | $259.28 | 2023-2024 | Desara |
| Davol INC. | $193.10 | 2025 | Arista |
| Merck Sharp & Dohme LLC | $187.88 | 2019-2020 | |
| Emd Serono, INC. | $160.26 | 2019-2022 | |
| Hologic Sales and Service, LLC | $129.59 | 2024 | Fluent Fluid Management System, Acessa Provu System, Myosure Tissue Removal Device |
| Baxter Healthcare | $79.31 | 2019-2020 | |
| Myovant Sciences INC. | $42.72 | 2021-2022 | |
| Minerva Surgical, INC | $32.20 | 2022 | |
| Cook Medical LLC | $31.23 | 2022 | |
| Medtronic, INC. | $28.90 | 2021-2023 | Truclear |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $21.01 | 2019 | |
| Covidien LP | $17.55 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Gocial listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.